A carregar...

Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation

The combination of a calcineurin inhibitor (cyclosporine [CSA] or tacrolimus [Tac]) and methotrexate (MTX) or mycophenolate mofetil (MMF) are widely used approaches to graft-versus-host disease (GVHD) prevention. There is limited and conflicting data, however, on the comparative effectiveness of MMF...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Hamilton, Betty K., Liu, Ying, Hemmer, Michael T., Majhail, Navneet, Ringden, Olle, Kim, Dennis, Costa, Luciano, Stuart, Robert, Alousi, Amin, Pidala, Joseph A., Couriel, Daniel R., Aljurf, Mahmoud, Antin, Joseph H., Bredeson, Christopher, Cahn, Jean-Yves, Cairo, Mitchell, Choi, Sung Won, Dandoy, Christopher, Gale, Robert Peter, Gergis, Usama, Hematti, Peiman, Inamoto, Yoshihiro, Kamble, Rammurti T., MacMillan, Margaret, Marks, David I., Nemecek, Eneida, Nishihori, Taiga, Saad, Ayman, Savani, Bipin N., Schriber, Jeff, Seo, Sachiko, Socié, Gérard, Teshima, Takanori, Verdonck, Leo F., Waller, Edmund K., Wirk, Mona, Spellman, Stephen R., Arora, Mukta, Chhabra, Saurabh
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039394/
https://ncbi.nlm.nih.gov/pubmed/31158502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.05.019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!